Cresco Labs (CRLBF) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Cresco Labs (CRLBF) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.94% |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | -1.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.79% |
| Dec 31, 2025 | -5.12% |
| Sep 30, 2025 | -7.18% |
| Jun 30, 2025 | -7.16% |
| Mar 31, 2025 | -6.00% |
| Dec 31, 2024 | -6.37% |
| Sep 30, 2024 | -7.96% |
| Jun 30, 2024 | -7.73% |
| Mar 31, 2024 | -7.83% |
| Dec 31, 2023 | -70.71% |
| Sep 30, 2023 | 1.28% |
| Mar 31, 2023 | -1.12% |
| Dec 31, 2022 | 240.74% |
| Sep 30, 2022 | 9.74% |
| Mar 31, 2022 | 57.98% |
| Dec 31, 2021 | 317.67% |
| Dec 31, 2020 | -52.50% |